Thymic alterations in GM2 gangliosidoses model mice

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Kanzaki, Seiichi ^a   Yamaguchi, Akira ^a   Yamaguchi, Kayoko ^a   Kojima, Yoshitsugu ^a   Suzuki, Kyoko ^a   Koumitsu, Noriko ^a   Nagashima, Yoji ^a   Nagahama, Kiyotaka ^a   Ehara, Michiko ^a   Hirayasu, Yoshio ^a   Ryo, Akihide ^a   Aoki, Ichiro ^a   Yamanaka, Shoji ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA N ACETYLHEXOSAMINIDASE; CD19 ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD79A ANTIGEN; CD79B ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; COLONY STIMULATING FACTOR 2 RECEPTOR 1; COLONY STIMULATING FACTOR RECEPTOR; COMPLEMENTARY DNA; CXCL13 CHEMOKINE; EARLY B CELL FACTOR 1; FC RECEPTOR; GANGLIOSIDE GM2; GENE PRODUCT; GLYCOLIPID; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR ALPHA; INTERLEUKIN 10 RECEPTOR BETA; INTERLEUKIN 13 RECEPTOR ALPHA1; MACROPHAGE EXPRESSED PROTEIN 1; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCYTE TO MACROPHAGE DIFFERENTIATION ASSOCIATED PROTEIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; BETA N ACETYLHEXOSAMINIDASE BETA CHAIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BRAIN CORTEX; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMOTAXIS; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; GENE DISRUPTION; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INFANT; INVOLUTION; LYMPHOCYTE COUNT; LYSOSOME STORAGE DISEASE; MACROPHAGE; MALE; MICROARRAY ANALYSIS; MOUSE; NEWBORN; NONHUMAN; SANDHOFF DISEASE; T LYMPHOCYTE; THYMOCYTE; THYMUS ATROPHY; UPREGULATION; AGING; ANIMAL; ATROPHY; BIOSYNTHESIS; CELL DEATH; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; GM2 GANGLIOSIDOSIS; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; PATHOLOGY; THYMUS;

ANIMALIA; MUS;

AGING; ANIMALS; ATROPHY; AUTOANTIBODIES; AUTOIMMUNITY; BETA-HEXOSAMINIDASE BETA CHAIN; CELL DEATH; CHEMOKINE CXCL13; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GANGLIOSIDOSES, GM2; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFANT; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; RECEPTORS, IGG; RNA, MESSENGER; SANDHOFF DISEASE; THYMUS GLAND;

EID: 77957816698     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012105     Document Type: Article

References (47)

1. Neufeld EF (1991) Lysosomal storage diseases. Annu Rev Biochem 60: 257-280.
2. Gravel RA, Clarke JTR, Kaback MM, Mahuran D, Sandhoff K, et al. (2001) The GM2 gangliosidoses. In: Scriver CR, Beaudet AL, Sly WS, editors. The metabolic and molecular basis of inherited disease. 7th ed. New York: McGraw-Hill. New York. pp. 3827-3876.
3. Yamanaka S, Johnson ON, Norflus F, Boles DJ, Proia RL (1994) Structure and expression of the mouse β-hexosaminidase genes, Hexa and Hexb. Genomics 1994 21: 588-596.
4. Sango K, Yamanaka S, Hoffmann A, Okuda Y, Grinberg A, et al. (1995) Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Mice lacking both subunits of lysosomal β-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nat Genet 11: 170-176.
5. Phaneuf D, Wakamatsu N, Huang J-Q, Borowski A, Peterson AC, et al. (1996) Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum Mol Genet 5: 1-14.
6. Huang JQ, Trasler JM, Igdoura S, Michaud J, Hanal N, et al. (1997) Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases. Hum Mol Genet 6: 1879-1885.
7. Norflus F, Tifft CJ, McDonald MP, Goldstein G, Crawley JN, et al. (1999) Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice. J Clin Invest 101: 1881-1888.
8. Wada R, Tifft CJ, Proia RL (2000) Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc Natl Acad Sci USA 97: 10954-10959.
9. Castaneda JA, Lim MJ, Cooper JD, Pearce DA (2008) Immune system irregularities in lysosomal storage disorders. Acta Neuropathol 115: 159-174.
10. Yamaguchi A, Katsuyama K, Nagahama K, Takai T, Aoki I, et al. (2004) Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses. J Clin Invest 113: 200-208.
11. DiRosario J, Divers E, Wang C, Etter J, Charrier A, et al. (2008) Innate and adaptive immune activation in the brain of MPS IIIB mouse model. J Neurosci Res 87: 978-990.
12. Chattopadhyay S, Ito M, Cooper JD, Brooks AI, Curran TM, et al. (2002) An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Hum Mol Genet 11: 1421-1431.
13. Lim MJ, Alexander N, Benedict JW, Chattopadhyay S, Shemilt SJA, et al. (2007) IgG entry and deposition are components of the neuroimmune response in Batten disease. Neurobiol Dis 25: 239-251.
14. Ramirez-Montealegre D, Chattopadhyay S, Curran TM, Wasserfall C, Pritchard L, et al. (2005) Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Neurology 64: 743-745.
15. Pearce DA, Atkinson M, Tagle DA (2004) Glutamic acid decarboxylase autoimmunity in Batten disease and other disorders. Neurology 63: 2001-2005.
16. Shoenfeld Y, Beresovski A, Zharhary D, Tomer Y, Swissa M, et al. (1995) Natural autoantibodies in sera of patients with Gaucher's disease. J Clin Immunol 15: 363-372.
17. Balreira A, Lacerda L, Miranda CS, Arosa FA (2005) Evidence for a link between sphingolipid metabolism and expression of CD1d and MHC-class II: monocytes from Gaucher disease patients as a model. Br J Haematol 129: 667-676.
18. Zhou J, Shao H, Cox NR, Baker HJ, Ewald SJ (1998) Gangliosides enhance apoptosis of thymocytes. Cell Immunol 183: 90-98.
19. Cox NR, Ewald SJ, Morrison NE, Gentry AS, Schuler M, et al. (1998) Thymic alterations in feline GM1 gangliosidosis. Vet Immunol Immunopathol 63: 335-353.
20. Zhou J, Cox NR, Ewald SJ, Morrison NE, Basker HJ (1998) Evaluation of GM1 ganglioside-mediated apoptosis in feline thymocytes. Vet Immunol Immunopathol 66: 25-42.
21. Galbiati F, Basso V, Cantuti L, Givogri MI, Lopez-Rosas A, et al. (2007) Autonomic denervation of lymphoid organs leads to epigenetic immune atrophy in a mouse model of Krabbe disease. J Neurosci 27: 13730-13738.
22. Gadola SD, Silk JD, Jeans A, Illarionov PA, Salio M, et al. (2006) Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J Exp Med 203: 2293-2303.
23. Gerard C, Rollins BJ (2001) Chemokines and disease. Nat Immunol 2: 108-115.
24. + dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J Exp Med 193: 1393-1402.
25. Sato T, Ishikawa S, Akadegawa K, Ito T, Yurino H, et al. (2004) Aberrant B1 cell migration into the thymus results in activation of CD4 T cells through its potent antigen-presenting activity in the development of murine lupus. Eur J Immunol 34: 3346-3358.
26. Ishikawa S, Matsushima K (2007) Aberrant B1 cell trafficking in a murine model for lupus. Front Biosci 12: 1790-1803.
27. Hayakawa K, Hardy RR, Parks DR, Herzenberg LA (1983) The "Ly-1 B" cell subpopulations in normal, immunodefective, and autoimmune mice. J Exp Med 157: 202-218.
28. Herzenberg LA, Stall AM, Lalor PA, Sidman C, Moore WA, et al. (1986) The Ly-1 B cell lineage. Immunol Rev 93: 81-102.
29. Herzenberg LA (2000) B-1 cells: the lineage question revisited. Immunol Rev 175: 9-22.
30. Wu Y-P, Proia RL (2004) Deletion of macrophage-inflammatory protein 1α retards neurodegeneration in Sandhoff disease mice. Proc Natl Acad Sci U S A 101: 8425-8430.
31. Meraouna A, Cizeron-Clairac G, Panse RL, Bismuth J, Truffault F, et al. (2006) The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood 108: 432-440.
32. Ferri C, Colaci M, Battolla L, Giuggioli D, Sebastiani M (2006) Thymus alterations and systemic sclerosis. Rheumatology (Oxford) 45: 72-75.
33. Cavallotti D, D'Andrea V, Pastore FS, Leali FMT, Cavallotti C (2005) Pathogenesis of some neurological immune ultrastructural and morphometrical observations on rat thymus. Neurol Res 27: 41-46.
34. Zhou D, Mattner J, Cantu C, Schrantz N, Yin N, Gao Y, et al. (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786-1789.
35. Takahashi A, Saito K, Koizumi Y (1974) An autopsy case of Sandhoff disease. Beitr Pathol 152: 418-28.
36. Tatematsu M, Imaida K, Ito N, Togari H, Suzuki Y, et al. (1981) Sandhoff disease. Acta Pathol Jpn 31: 503-512.
37. Schwarting GA, Gajewski A (1981) Glycolipids of murine lymphocyte subpopulations: a defect in the levels of sialidase-sensitive sialosylated asialo GM1 in beige mouse lymphocytes. J Immunol 126: 2403-2407.
38. Schwarting GA, Gajewski A (1983) Glycolipids of murine lymphocyte subpopulations. Structural characterization of thymus gangliosides. J Biol Chem 258: 5893-5898.
39. Tsuji D, Kuroki A, Ishibashi Y, Itakura T, Kuwahara J, et al. (2005) Specific induction of macrophage inflammatory protein 1-α in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates. J Neurochem 92: 1497-1507.
40. Jeyakumar M, Thomas R, Elliot-Smith E, Smith DA, van der Spoel AC, et al. (2003) Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain 126: 974-987.
41. Kawane K, Ohtani M, Miwa K, Kizawa T, Kanbara Y, et al. (2004) Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443: 998-1002.
42. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, et al. (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-β. Nat Immunol 9: 857-865.
43. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, et al. (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9: 847-856.
44. Dostert C, Petrilli V, Van BR, Steele C, Mossman BT, et al. (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320: 674-677.
45. Muruve DA, Petrilli V, Zaiss AK, White LR, Clark SA, et al. (2008) The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452: 103-107.
46. Petrilli V, Dostert C, Muruve DA, Tschopp J (2007) The inflammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol 19: 615-622.
47. Itoh H, Tanaka J, Morihana Y, Tamaki T (1984) The fine structure of cytoplasmic inclusions in brain and other visceral organs in Sandhoff disease. Brain Dev 6: 467-474.